Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies.
Lafaille, Florian
Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies. [electronic resource] - Analytical chemistry Nov 2012 - 9865-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1520-6882
10.1021/ac3021483 doi
Animals
Antineoplastic Agents--chemistry
Chromatography, Liquid
Deuterium Exchange Measurement
Dogs
Magnetic Resonance Spectroscopy
Mass Spectrometry
Microsomes, Liver--metabolism
Oxygen--chemistry
Quinoxalines--chemistry
Rats
Characterization of a new anticancer agent, EAPB0203, and its main metabolites: nuclear magnetic resonance and liquid chromatography-mass spectrometry studies. [electronic resource] - Analytical chemistry Nov 2012 - 9865-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1520-6882
10.1021/ac3021483 doi
Animals
Antineoplastic Agents--chemistry
Chromatography, Liquid
Deuterium Exchange Measurement
Dogs
Magnetic Resonance Spectroscopy
Mass Spectrometry
Microsomes, Liver--metabolism
Oxygen--chemistry
Quinoxalines--chemistry
Rats